Search

Author/Creator Papp, Kim

1. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. (1st June 2020)

Authors:
Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.; Vender, Ronald; Lomaga, Mark A.; Delorme, Isabelle
Journal:
British journal of dermatology
Issue:
Volume 182:Number 6(2020)
Page Start:
1348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris. Issue 1 (January 2016)

Authors:
Taraska, Victoria; Tuppal, Raj; Olesen, Martin; Bang Pedersen, Claus; Papp, Kim
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 20:Issue 1(2016:Jan./Feb)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure. Issue 2 (27th May 2021)

Authors:
Burmester, Gerd R; Nash, Peter; Sands, Bruce E; Papp, Kim; Stockert, Lori; Jones, Thomas V; Tan, Huaming; Madsen, Ann; Valdez, Hernan; Cohen, Stanley B
Journal:
RMD open
Issue:
Volume 7:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. An Open Letter to Health Canada. Issue 3 (May 2017)

Authors:
Papp, Kim; Albrecht, Lorne; Barber, Kirk; Bourcier, Marc; Dion, Pierre-Luc; Freiman, Anatoli; Gooderham, Melinda; Guenther, Lyn; Gulliver, Wayne; Hong, Chi-ho; Lynde, Charles; Poulin, Yves; Siddha, Sanjay; Toole, John; Toth, Darryl; Vender, Ronald; Wasel, Norman; Wiseman, Marni
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 21:Issue 3(2017:May/Jun.)
Page Start:
195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Issue 9993 (8th August 2015)

Authors:
Griffiths, Christopher E M; Reich, Kristian; Lebwohl, Mark; van de Kerkhof, Peter; Paul, Carle; Menter, Alan; Cameron, Gregory S; Erickson, Janelle; Zhang, Lu; Secrest, Roberta J; Ball, Susan; Braun, Daniel K; Osuntokun, Olawale O; Heffernan, Michael P; Nickoloff, Brian J; Papp, Kim
Journal:
Lancet
Issue:
Volume 386:Issue 9993(2015)
Page Start:
541
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF). Issue 6 (November 2016)

Authors:
Alavi, Afsaneh; Adam, David N.; Alhusayen, Ra'ed; Boucier, Marc; Brassard, Alain; Coutts, Pat; Gooderham, Melinda; Gulliver, Wayne; Hong, Chih-ho; Lynde, Charles; Marcoux, Danielle; Papp, Kim; Poulin, Yves; Sibbald, R. Gary; Shear, Neil H.
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 20:Issue 6(2016:Nov./Dec.)
Page Start:
613
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗